Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Psychopharmacology

• Publication date

  2001-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s002130100725PMID 11441422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications

  2005cited by this paper
• Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers

  2005cited by this paper
• Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat

  2005cited by this paper
• 11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET

  2005cited by this paper
• Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats

  2004cited by this paper
• Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D1 dopamine antagonist SCH 23390

  2004cited by this paper
• Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390

  2004cited by this paper
• Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine

  2004cited by this paper
• Risperidone for the treatment of cocaine dependence: randomized, double-blind trial.

  2000cited by this paper
• Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans

  1999cited by this paper
• Effects of dopamine receptor antagonists (D1 and D2) on the demand for smoked cocaine base in rhesus monkeys

  1999cited by this paper
• Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)

  1999cited by this paper
• Dopamine Receptor Antagonists Fail to Prevent Induction of Cocaine Sensitization

  1998cited by this paper
• Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers.

  1998cited by this paper
• Acute deleterious effects of cocaine on cardiac conduction, hemodynamics, and ventricular fibrillation threshold: effects of interaction with a selective dopamine D1 antagonist SCH 39166.

  1998cited by this paper
• Effects of pergolide on intravenous cocaine self-administration in men and women

  1998cited by this paper
• In vivo Amygdala Dopamine Levels Modulate Cocaine Self‐administration Behaviour in the Rat: D1 Dopamine Receptor Involvement

  1997cited by this paper
• Enhanced neurobehavioral effects of cocaine with chronic neuroleptic exposure in rats.

  1997cited by this paper
• Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists

  1997cited by this paper
• Preclinical Evaluation of Pharmacotherapies for Treatment of Cocaine and Opioid Abuse Using Drug Self-Administration Procedures

  1996cited by this paper
• Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure

  1996cited by this paper
• Effects of drugs on food- and cocaine-maintained responding III: Dopaminergic antagonists

  1996cited by this paper
• Role of dopamine D1 receptors in cocaine lethality.

  1995cited by this paper
• Discriminative stimulus effects of esteratic local anesthetics in squirrel monkeys.

  1995cited by this paper
• A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development

  1995cited by this paper
• Discriminative stimulus effects of cocaine: antagonism by dopamine D1 receptor blockade in the amygdala.

  1995cited by this paper
• Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats

  1995cited by this paper
• Dopamine antagonist effects on behavior maintained by cocaine and alfentanil in rhesus monkeys

  1994cited by this paper
• Dopamine receptors: molecular biology, biochemistry and behavioural aspects.

  1994cited by this paper
• Effects of buprenorphine on the self‐administration of cocaine by humans

  1994cited by this paper
• Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat.

  1994cited by this paper
• Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.

  1993cited by this paper
• Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement.

  1993cited by this paper
• Parameters of self-administration of cocaine in rats under a progressive-ratio schedule.

  1993cited by this paper
• Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat.

  1992cited by this paper
• Effects of chronic SCH 23390 or acute EEDQ on the discriminative stimulus effects of SKF 38393.

  1992cited by this paper
• Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D1 dopamine antagonists SCH‐39166 and A‐66359

  1991cited by this paper
• Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes.

  1991cited by this paper
• Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat

  1991cited by this paper
• Effects of cocaine alone and in combination with haloperidol and SCH 23390 on cardiovascular function in squirrel monkeys.

  1991cited by this paper
• Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey.

  1991cited by this paper
• Effects of continuous infusions of SCH 23390 on cocaine- or food‐maintained behavior in rhesus monkeys

  1990cited by this paper
• Demonstration of naturalistic methods for cocaine smoking by human volunteers.

  1990cited by this paper
• Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys.

  1990cited by this paper
• Effects of desipramine maintenance on cocaine self-administration by humans.

  1990cited by this paper
• Antagonism of cocaine self‐administration by selective dopamine D1 and D2 antagonists

  1990cited by this paper
• The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food.

  1989cited by this paper
• Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.

  1989cited by this paper
• Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade.

  1988cited by this paper
• Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.

  1988cited by this paper
• A psychomotor stimulant theory of addiction.

  1987cited by this paper
• Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

  1987cited by this paper
• The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.

  1987cited by this paper
• Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.

  1986cited by this paper
• Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys.

  1986cited by this paper
• Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.

  1985cited by this paper
• Behavioral and pharmacological aspects of opioid dependence: mixed agonist-antagonists.

  1983cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• MECHANISMS: A CRITICAL REVIEW OF THE CATECHOLAMINE THEORY

  1978cited by this paper

• Effects of the μ-opioid peptide and nociceptin/orphanin FQ peptide receptor agonist BU08028 on cocaine self-administration in male rhesus monkeys.

  2025cites this paper
• ROLE OF DOPAMINE IN THE REGULATION OF CARDIOVASCULAR SYSTEM

  2024cites this paper
• Natural Product-Inspired Dopamine Receptor Ligands

  2024cites this paper
• Chlorpromazine, an Inverse Agonist of D1R-Like, Differentially Targets Voltage-Gated Calcium Channel (CaV) Subtypes in mPFC Neurons

  2023cites this paper
• Empirical mode decomposition of local field potential data from optogenetic experiments

  2023cites this paper
• The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine.

  2023cites this paper
• Clinical neuropharmacology of cocaine reinforcement: A narrative review of human laboratory self-administration studies.

  2022cites this paper
• Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders.

  2022cites this paper
• Interactions between the intrarenal dopaminergic and the renin-angiotensin systems in the control of systemic arterial pressure.

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications

  2021cites this paper
• Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.

  2021cites this paper
• Modafinil reduces smoked cocaine self-administration in humans: effects vary as a function of cocaine 'priming' and cost.

  2021cites this paper
• Effects of the selective dopamine D3 receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice

  2020cites this paper
• Improving translation of animal models of addiction and relapse by reverse translation

  2020cites this paper
• Improving translation of animal models of addiction and relapse by reverse translation

  2020cites this paper
• Lipid Rafts and Dopamine Receptor Signaling

  2020cites this paper
• The Persistent Challenge of Developing Addiction Pharmacotherapies.

  2020cites this paper
• Lack of effect of the combination of metyrapone and oxazepam on brain dopamine.

  2019cites this paper
• Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics.

  2019cites this paper
• Dopamine receptor antagonists effects on low-dimensional attractors of local field potentials in optogenetic mice

  2019cites this paper
• (-)-Stepholidine reduces cue-induced reinstatement of cocaine seeking and cocaine self-administration in rats.

  2018cites this paper
• The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal

  2018cites this paper
• Evaluation of efavirenz on neurochemical and oxidative stress markers and addictive-like behaviours in rats

  2018cites this paper
• Synthesis and structure–activity relationship study of diaryl[d,f][1,3]diazepines as potential anti-cancer agents

  2018cites this paper
• Dopamine Pretreatment Protects Offspring Rats from LPS-Induced Hypertension and Kidney Damage by Inhibiting NLRP3 Activation in Kidney

  2018cites this paper
• Dopamine and addiction: what have we learned from 40 years of research

  2018cites this paper
• Unmasking the gut-brain axis: How the microbiota influences brain and behavior.

  2018cites this paper
• The “highs and lows” of the human brain on dopaminergics: Evidence from neuropharmacology

  2017cites this paper
• Gut–Brain Axis in Regulation of Blood Pressure

  2017cites this paper
• Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.

  2017cites this paper
• 2 Running title : Effects D 2 and D 3 ligands on cocaine choice in rats

  2017cites this paper
• Morphine responsiveness to thermal pain stimuli is aging-associated and mediated by dopamine D1 and D3 receptor interactions.

  2017cites this paper
• Effects of acute and chronic treatments with dopamine D 2 and D 3 receptor ligands on cocaine vs. food choice in rats

  2017cites this paper
• Effects of Acute and Chronic Treatments with Dopamine D2 and D3 Receptor Ligands on Cocaine versus Food Choice in Rats

  2017cites this paper
• Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats

  2017cites this paper
• Dopamine D1 and D3 Receptor Polypharmacology in Cocaine Reward and Cocaine Seeking

  2017cites this paper
• Medication Strategies for the Management of Cocaine Use Disorder

  2017cites this paper
• Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain

  2017cites this paper
• Medications for substance use disorders (SUD): emerging approaches

  2017cites this paper
• The pharmacology of effort-related choice behavior: Dopamine, depression, and individual differences.

  2016cites this paper
• Deconjugative alkylation/Heck reaction as a simple platform for dihydronaphthalene synthesis.

  2016cites this paper
• Neuroscience of learning and memory for addiction medicine: from habit formation to memory reconsolidation.

  2016cites this paper
• Targeting the trace amine-associated receptor 1 in psychomotor stimulant addiction.

  2016cites this paper
• Polypharmacology of dopamine receptor ligands.

  2016cites this paper
• Influence of local and circuit-wide modulation of the mesocorticolimbic reward system on the reinstatement of cocaine seeking

  2016cites this paper
• Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse

  2016cites this paper
• Orexin modulation of ventral tegmental area dopamine neurons

  2016cites this paper
• A clinical trial of safety and tolerability for the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease.

  2016cites this paper
• Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine.

  2016cites this paper
• A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease.

  2016cites this paper
• Effects of 21-day d-amphetamine and risperidone treatment on cocaine vs food choice and extended-access cocaine intake in male rhesus monkeys.

  2016cites this paper
• Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.

  2016cites this paper
• Agonist Medications for the Treatment of Cocaine Use Disorder

  2015cites this paper
• Polypharmacology of dopamine D1-like receptor antagonists

  2015cites this paper
• Dopamine D₄ Receptor Antagonists for the Treatment of Cocaine Use Disorders.

  2015cites this paper
• Cocaine choice procedures in animals, humans, and treatment-seekers: Can we bridge the divide?

  2015cites this paper
• The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.

  2015cites this paper
• Stimulant Use Disorders

  2015cites this paper
• Use of Preclinical Drug Vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction

  2015cites this paper
• Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse

  2014cites this paper
• Validation of oral fluid as a matrix for drug detection

  2014cites this paper
• Dopamine D1 and D3 receptors mediate reconsolidation of cocaine memories in mouse models of drug self-administration.

  2014cites this paper
• Gender as a Moderator of the Effects of D2 and D2 Dopamine Antagonists on Gambling and Amphetamine Reinforcement in Pathological Gamblers and Healthy Controls

  2014cites this paper
• Dopaminergic Modulation of Neuroplasticity in Humans- Contribuition of Receptor Subtypes and Dosage

  2014cites this paper
• Effects of Dopamine D2/D3 Receptor Ligands on Food-Cocaine Choice in Socially Housed Male Cynomolgus Monkeys

  2013cites this paper
• Sweet liking in patients with Parkinson's disease.

  2013cites this paper
• Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

  2013cites this paper
• Acute and chronic effects of the M1/M4-preferring muscarinic agonist xanomeline on cocaine vs. food choice in rats

  2013cites this paper
• In the company of others: social factors alter acute alcohol effects

  2013cites this paper
• Pregabalin reduces cocaine self‐administration and relapse to cocaine seeking in the rat

  2013cites this paper
• Development of an integrative cessation program for co-smokers of cigarettes and cannabis: demand analysis, program description, and acceptability

  2013cites this paper
• The Influence of Early Life Adversity and Social Cue on Cocaine-Induced Dopamine Release in the Nucleus Accumbens

  2013influential citation
• Kappa-Opioid Receptor Signaling in the Striatum as a Potential Modulator of Dopamine Transmission in Cocaine Dependence

  2013cites this paper
• A double-blind placebo control pilot study on the safety and tolerability of Nabilone in marijuana users

  2013cites this paper
• Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.

  2013cites this paper
• Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys

  2012cites this paper
• Rational development of addiction pharmacotherapies: successes, failures, and prospects.

  2012cites this paper
• Design, synthesis, and pharmacological evaluation of novel tetrahydroprotoberberine derivatives: selective inhibitors of dopamine D₁ receptor.

  2012cites this paper
• Catalytic enantioselective synthesis of the dopamine D1 antagonist ecopipam

  2012cites this paper
• The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

  2012cites this paper
• Pharmacotherapy of Addiction

  2012cites this paper
• The Dopamine Augmenter L-DOPA Does Not Affect Positive Mood in Healthy Human Volunteers

  2012cites this paper
• A single-day paradigm of self-regulated human cocaine administration.

  2012cites this paper
• Agents in Development for the Management of Cocaine Abuse

  2012cites this paper
• Multiple roles for orexin/hypocretin in addiction.

  2012cites this paper
• The mysterious motivational functions of mesolimbic dopamine.

  2012cites this paper
• Comparative Effects of a D2 and Mixed D1-D2 Dopamine Receptor Antagonist on Amphetamine Reinforcement in Pathological Gamblers and Healthy Controls

  2012cites this paper
• Recent Advances in Management of Psycho- Active Substance Abuse and Dependence

  2011cites this paper
• A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans

  2011cites this paper
• Genetics of Salt-Sensitive Hypertension

  2011cites this paper
• Prolonged Attenuation of the Reinforcing Strength of Cocaine by Chronic d-Amphetamine in Rhesus Monkeys

  2011cites this paper
• Aripiprazole maintenance increases smoked cocaine self-administration in humans

  2011cites this paper
• Dopamine Receptors: Important Antihypertensive Counterbalance Against Hypertensive Factors

  2011cites this paper
• Antagonist-Elicited Cannabis Withdrawal in Humans

  2011cites this paper
• Synthesis of New Dopamine D1 Antagonist SCH 23390 Analogues by the Stereoselective Stevens Rearrangement

  2011cites this paper
• Effects of monoamine releasers with varying selectivity for releasing dopamine/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys

  2011cites this paper
• Neuroscience of behavioral and pharmacological treatments for addictions.

  2011cites this paper
• Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans

  2011cites this paper
• Potential Pharmacotherapies for Cannabis Dependence

  2010cites this paper